Market Overview
The U.S. Biopharmaceuticals Contract Manufacturing Market is experiencing robust growth, projected to expand from USD 4,555.40 million in 2023 to USD 16,804.92 million by 2032, reflecting a remarkable compound annual growth rate (CAGR) of 15.61%. This growth can be attributed to the increasing demand for biopharmaceutical products, advancements in manufacturing technologies, and the rise of personalized medicines. The U.S. market stands as a global leader in contract manufacturing